Pfizer has agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration, President Donald Trump said Tuesday as he promised similar deals with other ...

Pfizer’s stock surged after CEO Albert Bourla announces an agreement with the Trump administration aimed at lowering drug prices in the U.S. and removing tariff uncertainty.

Pfizer has agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration, President Donald Trump said Tuesday as he promised similar deals with ...

It’s unclear how the new policy will affect Medicaid patients who often pay a nominal co-payment of a few dollars to fill their prescriptions, but ...

President Donald Trump and the CEO of Pfizer announce a new drug pricing deal to lower drug costs for Americans.

Pfizer Inc CEO Albert Bourla said the company secured a three-year grace period from President Donald Trump's promised tariffs on pharmaceuticals in a deal that would lower some of the company's US ...

Albert Bourla, chairman and chief executive officer of the pharmaceutical company Pfizer, speaks Tuesday in the Oval Office of the White House in Washington, as from left, Secretary of Health and ...

Merck & Co. Inc., (NYSE:MRK) is one of the best conservative stocks to buy now. On September 23, the company confirmed a strategic collaboration with Variational AI to leverage its Enki Platform in ...

The announcement, which Trump made with Pfizer CEO Albert Bourla at the White House, came as the Republican president has for months sought to lower drug costs. It also came as Washington faced a ...

Shares of Pfizer, the Indian arm of U.S.-based Pfizer Inc., rose more than 2% on Wednesday after President Donald Trump announced a deal with the drugmaker to provide key prescription medications at ...